BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1670616)

  • 1. Use of neuroleptic-induced extrapyramidal symptoms to predict future vulnerability to side effects.
    Keepers GA; Casey DE
    Am J Psychiatry; 1991 Jan; 148(1):85-9. PubMed ID: 1670616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Painful sensory symptoms in neuroleptic-induced extrapyramidal syndromes.
    Decina P; Mukherjee S; Caracci G; Harrison K
    Am J Psychiatry; 1992 Aug; 149(8):1075-80. PubMed ID: 1353315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
    Keepers GA; Casey DE
    Curr Psychiatr Ther; 1986; 23():139-57. PubMed ID: 2870879
    [No Abstract]   [Full Text] [Related]  

  • 4. Extrapyramidal side effects: a historical perspective.
    Rifkin A
    J Clin Psychiatry; 1987 Sep; 48 Suppl():3-6. PubMed ID: 2887555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute extrapyramidal syndromes in neuroleptic-treated elders: a pilot study.
    Ganzini L; Heintz R; Hoffman WF; Keepers GA; Casey DE
    J Geriatr Psychiatry Neurol; 1991; 4(4):222-5. PubMed ID: 1686396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy.
    Hriso E; Kuhn T; Masdeu JC; Grundman M
    Am J Psychiatry; 1991 Nov; 148(11):1558-61. PubMed ID: 1681751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
    Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
    Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM; Cellar JS; Bowers MB; Nelson JC; Takeshita J; Zigun B
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protocol for the diagnosis and treatment of extrapyramidal symptoms of neuroleptic drugs.
    Bickal T
    Nurse Pract; 1987 Jan; 12(1):25, 29, 32 passim. PubMed ID: 2880325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.
    Bezchlibnyk-Butler KZ; Remington GJ
    Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of extrapyramidal syndromes in AIDS patients and a comparison group of medically ill inpatients.
    Ramachandran G; Glickman L; Levenson J; Rao C
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):579-83. PubMed ID: 9447500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute neuroleptic-induced movement disorders.
    Tonda ME; Guthrie SK
    Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced extrapyramidal syndromes.
    Lader MH
    J R Coll Physicians Lond; 1970 Oct; 5(1):87-98. PubMed ID: 4150143
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapyramidal side effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication.
    Caligiuri MP; Rockwell E; Jeste DV
    Am J Geriatr Psychiatry; 1998; 6(1):75-82. PubMed ID: 9469217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ; Simpson GM; Morrison RL; Heiser JF
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.
    Dose M
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():3-13. PubMed ID: 11072761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
    Moritz S; Krausz M; Gottwalz E; Andresen B
    Compr Psychiatry; 2000; 41(4):284-8. PubMed ID: 10929797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic induced extrapyramidal symptoms.
    Donlon PT; Stenson RL
    Dis Nerv Syst; 1976 Nov; 37(11):629-35. PubMed ID: 136337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.